Page last updated: 2024-11-02

oxonic acid and ATLL

oxonic acid has been researched along with ATLL in 1 studies

Oxonic Acid: Antagonist of urate oxidase.

Research Excerpts

ExcerptRelevanceReference
"The involvement of S-1 chemotherapy in ATLL development suggests that a test for HTLV-1 antibody should be performed before treatment and that S-1 should not be administered in HTLV-1 positive patients with head and neck carcinoma."1.46Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy. ( Kurono, Y; Matushita, K; Nagano, H, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagano, H1
Kurono, Y1
Matushita, K1

Other Studies

1 other study available for oxonic acid and ATLL

ArticleYear
Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C

2017